Furthermore, we added reagents that could dissociate the binding of hexokinase and VDAC1, including methyl jasmonate and clotrimazole, to cisplatin in the SiHa and CaSki cervical cancer cells to detect their effects on cell viability. This evidence concerns the gene VDAC1 and cervical cancer.